in this issue
People & Business :: Emerging Companies
Merck KGaA Launches Fund
11:14 AM MDT | April 10, 2009
Merck KGaA says it has launched a venture capital fund, called Merck Serono Ventures, to invest in emerging biotechnology companies. The fund aims to support biotech startup companies that have the potential to provide innovative products in Merck Serono’s core therapeutic areas such as neurodegenerative diseases, oncology and autoimmune and inflammatory diseases. The fund will invest up to €40 million ($53 million) during the next five...
This information is only available to Chemical Week subscribers.
Forgot your user ID or password?
Not an IHS Chemical Week member yet?
Here's why you should be:
100% Satisfaction Guarantee